InfertilityNCT06924437
Evaluation of the Uterine Cavity After Operative Hysteroscopy
An observational study of Infertility and Abnormal Uterine Bleeding (AUB), run by Sohag University at 1 site in Egypt.
Trial summary
This study will focus on evaluation of the uterine cavity after operative hysteroscopy using three dimensional transvaginal ultrasonography and office hysteroscopy to detect and residual or recurrent abnormalities or intrauterine adhesions to optimize the results of operative hysteroscopy in different uterine… Read more about this study
- Who is it for?
- Ages 18 to 45 years, women only
- Conditions the study is for
- Infertility, Abnormal Uterine Bleeding (AUB), Intrauterine Adhesion
- How many people
- 50 participants
- Where
- 1 siteEgypt
- Study dates
- 31 Mar 2025to 8 Jun 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- No healthy volunteers
- Adult
Study population: It will be held in the department of Obstetrics and Gynecology during the period from February 2025 to February 2026. The study will include all recruited patients who will be selected for operative hysteroscopy during that period.
Who may be able to join
- Patients in reproductive age group
- Patients already selected for operative hysteroscopy
- Patients accepted to share in the study
- Patients accepted to come for follow up ( within 3 months after the initial operative procedure, at least after 4 weeks
Who cannot join
- Patients outside the age of reproduction
- Patients with negative findings at operative hysteroscopy
- Patients refused to share in the study
- Patients not available for follow up
- Infection
- pregnancy or design of pregnancy
Trial locations and contacts
1 site in 1 country.
About this study
This study will focus on evaluation of the uterine cavity after operative hysteroscopy using three dimensional transvaginal ultrasonography and office hysteroscopy to detect and residual or recurrent abnormalities or intrauterine adhesions to optimize the results of operative hysteroscopy in different uterine pathologies such as uterine polyps, fibroids, adhesions in addition to mullerian anomalies especially uterine septum .
- Conditions
- Infertility, Abnormal Uterine Bleeding (AUB), Intrauterine Adhesion, Submucous Leiomyoma of Uterus, Scar Niche, Uterine Septum
- Medical subject headings
- Infertility, Metrorrhagia, Gynatresia, Septate Uterus
What is being measured
The primary outcome is the main question the study is designed to answer.
Rate of bias in 3 dimensional ultrasonography compared to office hysteroscopy
Comparing three dimensional ultrasonography and office hysteroscopy for uterine cavity evaluation after operative hysteroscopy as regards accuracy, pain score, and cost-effectiveness of each method.
Measured: one year
Secondary outcomes (1)
Concentration of the risks and benefits between 3 dimensional ultrasonography and office hysteroscopy
To compare three dimensional ultrasonography with office hysteroscopy in evaluation of the uterine cavity after operative hysteroscopy and if the non invasive procedure can replace the invasive one or not
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Apr 2025
- Study start31 Mar 2025
- Primary completion31 Mar 2026
- Study completion8 Jun 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for InfertilityStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mai Allam Mohamed, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06924437
- Sponsor's protocol ID
- Soh-Med--25-3-05MS
- Status last verified
- Jul 2026
- First submitted
- 6 Apr 2025
- Last updated
- 14 Jul 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of the Uterine Cavity After Operative Hysteroscopy
- ClinicalTrials.gov ID
- NCT06924437
- Acronym / sponsor ID
- Soh-Med--25-3-05MS
- Conditions
- Infertility, Abnormal Uterine Bleeding (AUB), Intrauterine Adhesion, Submucous Leiomyoma of Uterus, Scar Niche, Uterine Septum
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 31 Mar 2025 (actual)
- Primary completion
- 31 Mar 2026 (actual)
- Study completion
- 8 Jun 2026 (actual)
- First posted
- 11 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will focus on evaluation of the uterine cavity after operative hysteroscopy using three dimensional transvaginal ultrasonography and office hysteroscopy to detect and residual or recurrent abnormalities or intrauterine adhesions to optimize the results of operative hysteroscopy in different uterine pathologies such as uterine polyps, fibroids, adhesions in addition to mullerian anomalies especially uterine septum .
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 45 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- It will be held in the department of Obstetrics and Gynecology during the period from February 2025 to February 2026. The study will include all recruited patients who will be selected for operative hysteroscopy during that period.
Key inclusion criteria (4 listed)
- Patients in reproductive age group
- Patients already selected for operative hysteroscopy
- Patients accepted to share in the study
- Patients accepted to come for follow up ( within 3 months after the initial operative procedure, at least after 4 weeks
Key exclusion criteria (6 listed)
- Patients outside the age of reproduction
- Patients with negative findings at operative hysteroscopy
- Patients refused to share in the study
- Patients not available for follow up
- Infection
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Rate of bias in 3 dimensional ultrasonography compared to office hysteroscopy
Time frame: one year
Comparing three dimensional ultrasonography and office hysteroscopy for uterine cavity evaluation after operative hysteroscopy as regards accuracy, pain score, and cost-effectiveness of each method.
1 secondary outcome
Concentration of the risks and benefits between 3 dimensional ultrasonography and office hysteroscopy
Time frame: 1 year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Jul 2026.
Related trials for Infertility
RecruitingObservational study
International Pilot Study for Dual Non-invasive Assesment of Embryo Development
Infertility
Active, not recruitingObservational study
Retrieval of Sperm From Men With Azoospermia Using Ultrasound-guided Rete Testis Aspiration
Azoospermia, Nonobstructive, Infertility, Male
Not yet recruiting
Spinery Basivertebral Nerve Ablation for Vertebrogenic Chronic Low Back Pain
Low Back Pain, Chronic Low Back Pain (CLBP)
RecruitingObservational study
Impact of Infertility on the Sexual Sphere in Couples Undergoing Assisted Reproduction
Sexual Health Quality of Life, Infertile Patients
RecruitingObservational study
Pilot Study of Discarded Blastocysts
Infertility (IVF Patients)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Infertility and Abnormal Uterine Bleeding (AUB), run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Rate of bias in 3 dimensional ultrasonography compared to office hysteroscopy (time frame: one year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jul 2026.